Sign inJoin waitlistJoin the waitlist

Jonathan Serody

Director, Cellular Therapy Program, UNC Medical Center · University of North Carolina Hospitals

Credentials: · · · ·

History

Division of Hematology · UNC-Chapel Hill
2019–Present
Hematology Division · University of North Carolina Hospitals
Present
Division of Hematology · University of North Carolina Hospitals
Present

Fred Hutchinson Cancer Research Center
1991–1993
UNC-Chapel Hill
1991–1993
Internal Medicine
University of North Carolina Hospitals
1989–1992
Infectious Disease
University of North Carolina Hospitals
1989–1991
Fred Hutchinson Cancer Research Center
1990–1991
University of Virginia School of Medicine
1985–1989
University of Virginia
1978–1982
Resident
University of North Carolina Hospitals

Research

The Immune Landscape of Cancer
Immunity · 2018 · 4,524 citations
Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy
Nature Nanotechnology · 2017 · 527 citations
B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer
Cell · 2019 · 397 citations

Bruce Blazar
54 papers
Benjamin Vincent
39 papers · 25 as a resident
TS
Thomas Shea
35 papers
James Coghill
26 papers
Geoffrey Hill
18 papers
David Munn
17 papers
Paul Armistead
16 papers
DG
Don Gabriel
15 papers
William Wood
15 papers
Ivan Maillard
14 papers
Leo Luznik
13 papers
Stefanie Sarantopoulos
13 papers

Grants

Enhancing Innate Immune Reconstitution Post Allogeneic HSCT
National Heart, Lung, and Blood Institute · R01
Contact PI · $3.5M · Univ of North Carolina Chapel Hill
2021–2030
UNC Immunotherapy Training Grant (IM-TAG)
National Cancer Institute · T32
Contact PI · $668K · Univ of North Carolina Chapel Hill
2023–2028
Selective Targeting of Pancreatic Cancer SPORE
National Cancer Institute · P50
Project lead · $429.7K · Univ of North Carolina Chapel Hill
2022–2027
Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $380.4K · Univ of North Carolina Chapel Hill
1997–2025

Clinical trials

Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Principal investigator · Completed · Phase 2
UNC Lineberger Comprehensive Cancer Center
2005–2017
Vaccine Therapy, Trastuzumab, and Vinorelbine in Treating Women With Locally Recurrent or Metastatic Breast Cancer
Study chair · Terminated · Phase 2
UNC Lineberger Comprehensive Cancer Center
2004–2009
Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Sub-investigator · Recruiting · Phase 1
UNC Lineberger Comprehensive Cancer Center
2020–2043